List of Archives

Back To Archive Home Page

The Journal of Orthomolecular Medicine Vol. 15, 3rd Quarter 2000


Therapeutic Effect of d-Lenolate Against Experimental Infections in Immuno-compromised Mice


Download The Full Text Article in (PDF)

Back to 2000 3rd Quarter Table of Contents

Back to 2000 archives

Subscribe to the JOM

Effects of a dietary supplement, d-Lenolate, on the host defence in immuno-compromised mice were investigated in terms of the restoration of leukocytopenia and the protection against several microbial infections. Lenolatepotentiated phagocytic activity of rat or mouse peritoneal yolymorphonuclear leukocytes (PMN) in vitro or in vivo, respectively. The agent enhanced nitroblue-tetrazoliiim (NET) reduc- ing capacities of rat and guinea pig polymorphonuclear leukocytes in the peripheral blood. Oral or intraperitoneal administration of Lenolate into mice prior to X-irradiation or treatment with cyclophosphamide (CY) prevented the leukocytopenia to some extent and promoted the restoration in the pfwgocytic activity of both the peripheral blood leukocytes and peritoneal macrophages. In addition, IL-1 production by mouse macrophages was augmented by cultiiring with the agent in vitro. Oral administration of Lenolate increased significantly the survival rates of X-irradiated mice against acute systemic infections with Escherichia coli, Pseudomonas aeruginosa and Candida albicans, and intramuscular infection with Esherichia coli.

[Home] [History] [Library] [Nutrients] [Resources] [Contact] [Contribute]
Back To Molecule

This website is managed by Riordan Clinic
A Non-profit 501(c)(3) Medical, Research and Educational Organization
3100 North Hillside Avenue, Wichita, KS 67219 USA
Phone: 316-682-3100; Fax: 316-682-5054
© (Riordan Clinic) 2004 - 2017

Information on is provided for educational purposes only. It is not intended as medical advice.
Consult your orthomolecular health care professional for individual guidance on specific health problems.